ES502965A0 - Procedimiento para la mutacion doble de virus del genero herpes - Google Patents

Procedimiento para la mutacion doble de virus del genero herpes

Info

Publication number
ES502965A0
ES502965A0 ES502965A ES502965A ES502965A0 ES 502965 A0 ES502965 A0 ES 502965A0 ES 502965 A ES502965 A ES 502965A ES 502965 A ES502965 A ES 502965A ES 502965 A0 ES502965 A0 ES 502965A0
Authority
ES
Spain
Prior art keywords
procedure
herpes viruses
double mutation
mutation
double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502965A
Other languages
English (en)
Other versions
ES8303522A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK
Asta Medica GmbH
Original Assignee
ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK
Asta Werke AG Chemische Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK, Asta Werke AG Chemische Fabrik filed Critical ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK
Publication of ES8303522A1 publication Critical patent/ES8303522A1/es
Publication of ES502965A0 publication Critical patent/ES502965A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661Methods of inactivation or attenuation
    • C12N2710/16663Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES502965A 1980-06-12 1981-06-11 Procedimiento para la mutacion doble de virus del genero herpes Granted ES502965A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8019308 1980-06-12

Publications (2)

Publication Number Publication Date
ES8303522A1 ES8303522A1 (es) 1983-02-01
ES502965A0 true ES502965A0 (es) 1983-02-01

Family

ID=10514018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502965A Granted ES502965A0 (es) 1980-06-12 1981-06-11 Procedimiento para la mutacion doble de virus del genero herpes

Country Status (7)

Country Link
US (1) US4322404A (es)
BE (1) BE889182A (es)
DE (1) DE3122669A1 (es)
ES (1) ES502965A0 (es)
FR (1) FR2484446A1 (es)
IT (1) IT8148649A0 (es)
NL (1) NL8102827A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
USRE33772E (en) * 1983-10-12 1991-12-17 Centraal Diergeneeskundig Instituut Deletion mutant of a herpesvirus and vaccine containing said virus
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
US6471965B1 (en) * 1994-07-27 2002-10-29 Bio-Virus Research Incorporated Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
US5837262A (en) * 1994-07-27 1998-11-17 Bio-Virus Research Incorporated Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
DK2287288T3 (da) * 2002-07-09 2013-01-07 Baxter Int Medium frit for animalsk protein til dyrkning af celler

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung

Also Published As

Publication number Publication date
IT8148649A0 (it) 1981-06-10
NL8102827A (nl) 1982-01-04
FR2484446A1 (fr) 1981-12-18
ES8303522A1 (es) 1983-02-01
DE3122669A1 (de) 1982-02-11
BE889182A (fr) 1981-12-11
US4322404A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
ES544281A0 (es) Un procedimiento para la preparacion de derivados del indol
AR229581A1 (es) Procedimiento para la elaboracion de derivados del alcohol 1-alpha-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico
MX153635A (es) Procedimiento mejorado para la eliminacion de alcalide polieterpolioles
IT1131976B (it) Procedimento per la fabbricazione del silicato sodico
ES504694A0 (es) Procedimiento para la preparacion de derivados del indol.
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
ES502965A0 (es) Procedimiento para la mutacion doble de virus del genero herpes
IT7819806A0 (it) Derivati del 2h-benzofuran-3-one eprocedimento per la loro preparazione.
AR228161A1 (es) Procedimiento para desintegrar derivados de 2,4-dihidroxi-6-amino-s-triazina
AR224674A1 (es) Conjunto de regletas de cierre de vapor para planchas de coccion de barquillo
ES507015A0 (es) Procedimiento para la preparacion de nuevas indolinonas.
ES499834A0 (es) Procedimiento para la obtencion de nuevos derivados del aci-do lignosulfonicos
ES504916A0 (es) Procedimiento para la preparacion de floculantes polimeros cationicos del tipo de acrilamida
ES502355A0 (es) Procedimiento para la obtencion de nuevos derivados del ben-zazol
MX6962E (es) Procedimiento para la preparacion de una composicion farmaceutica antidiarreica
IT1132528B (it) Procedimento per la preparazione di derivati del 15-idrossiimmino-e-omoeburano
IT1163500B (it) Procedimento per la preparazione del meta-clorobenzotrifluoruro
ATA338583A (de) Dampfsterilisator
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES487257A0 (es) Procedimiento para la polimerizacion de alfa-olefinas
IT1220957B (it) Derivati del ciclododecano e procedimento per la loro preparazione
MX5910E (es) Procedimiento mejorado para la preparacion del clorhidrato de p-clorofenoxiacetil-piperonilpiperazina
ES506682A0 (es) Procedimiento para la preparacion de ftalimidinas